Volume 1220; Issue none

International Congress Series

Volume 1220; Issue none
3

Clinical pharmacology of morphine and morphine-6-glucuronide. A PK/PD modeling approach

Jörn Lötsch
Journal:
International Congress Series
Year:
2001
Language:
english
File:
PDF, 200 KB
english, 2001
5

Dose optimization in drug development: role of phase IV trials

Pieter H. Joubert
Journal:
International Congress Series
Year:
2001
Language:
english
File:
PDF, 298 KB
english, 2001
6

PK/PD approach to dose selection

Lewis B. Sheiner
Journal:
International Congress Series
Year:
2001
Language:
english
File:
PDF, 93 KB
english, 2001
8

Pharmacokinetic–pharmacodynamic modeling in anesthesia

Pedro L. Gambús, Iñaki F. Trocóniz
Journal:
International Congress Series
Year:
2001
Language:
english
File:
PDF, 79 KB
english, 2001
9

Dose optimisation in pain control

Henry McQuay
Journal:
International Congress Series
Year:
2001
Language:
english
File:
PDF, 309 KB
english, 2001
10

The dose–concentration–effect relationships—the basis for TDM. A critical appraisal

Lars F. Gram
Journal:
International Congress Series
Year:
2001
Language:
english
File:
PDF, 63 KB
english, 2001
11

Medication non-compliance: When hard science meets soft science

Gerhard Levy
Journal:
International Congress Series
Year:
2001
Language:
english
File:
PDF, 74 KB
english, 2001
12

Concentration controlled therapy

Nicholas H.G Holford
Journal:
International Congress Series
Year:
2001
Language:
english
File:
PDF, 77 KB
english, 2001
14

The role of molecular biology in pharmacodynamic research

James Oliver, David J. Webb
Journal:
International Congress Series
Year:
2001
Language:
english
File:
PDF, 105 KB
english, 2001
17

Pharmacodynamics of cancer chemotherapy: childhood ALL as a model

William E. Evans
Journal:
International Congress Series
Year:
2001
Language:
english
File:
PDF, 183 KB
english, 2001
18

Dose optimisation in antidepressant drug development

Bill Deakin
Journal:
International Congress Series
Year:
2001
Language:
english
File:
PDF, 293 KB
english, 2001
19

Effect of liver disease on dose optimization

Terrence F. Blaschke
Journal:
International Congress Series
Year:
2001
Language:
english
File:
PDF, 87 KB
english, 2001
20

Dose optimisation—the effect of age

Stephen H.D Jackson
Journal:
International Congress Series
Year:
2001
Language:
english
File:
PDF, 181 KB
english, 2001
21

Final remarks

A. Breckenridge
Journal:
International Congress Series
Year:
2001
Language:
english
File:
PDF, 33 KB
english, 2001
22

Optimal Dose Identification

Journal:
International Congress Series
Year:
2001
File:
PDF, 5 KB
2001
23

Copyright/ISBN

Journal:
International Congress Series
Year:
2001
Language:
english
File:
PDF, 6 KB
english, 2001
24

About the Esteve Foundation

Journal:
International Congress Series
Year:
2001
Language:
english
File:
PDF, 4 KB
english, 2001
25

Disclaimer

Journal:
International Congress Series
Year:
2001
File:
PDF, 3 KB
2001
26

Introduction

Journal:
International Congress Series
Year:
2001
Language:
english
File:
PDF, 8 KB
english, 2001
27

Contents

Journal:
International Congress Series
Year:
2001
File:
PDF, 81 KB
2001
28

List of participants

Journal:
International Congress Series
Year:
2001
Language:
english
File:
PDF, 8 KB
english, 2001